# Can External Vagus Nerve Stimulation Reduce Systemic Levels of Inflammatory Mediators in Duchenne Muscular Dystrophy Patients?

> **NCT07543302** · NA · ENROLLING_BY_INVITATION · sponsor: **taVNS AB** · enrollment: 20 (estimated)

## Conditions studied

- Duchenne Muscular Dystrophy (DMD)

## Interventions

- **DEVICE:** Transcutaneous auricular vagus nerve stimulation

## Key facts

- **NCT ID:** NCT07543302
- **Lead sponsor:** taVNS AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-04-13
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07543302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07543302, "Can External Vagus Nerve Stimulation Reduce Systemic Levels of Inflammatory Mediators in Duchenne Muscular Dystrophy Patients?". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07543302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*